Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib and Best Supportive Care in Previously Treated Renal Cell Carcinoma: A Systematic Review and Economic Evaluation

Health Technology Assessment - United Kingdom
doi 10.3310/hta22060
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Institute for Health Research

Related search

Bevacizumab, Sorafenib Tosylate, Sunitinib and Temsirolimus for Renal Cell Carcinoma: A Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2010English

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2020English

Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma

European Urology
Urology
2016English

Pcn17 - Indirect Treatment Comparisons of Nivolumab Versus Regorafenib, Cabozantinib and Best Supportive Care After Treatment With Sorafenib for Hepatocellular Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Spotlight on Cabozantinib for Previously Untreated Advanced Renal Cell Carcinoma: Evidence to Date

Cancer Management and Research
Oncology
2018English

Pharmacoeconomic Evaluation of Axitinib Introduction in Metastatic Renal Cell Carcinoma Treatment Scheme

Pharmacoeconomics: theory and practice
2014English

Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

A Case of Metastatic Renal Cell Carcinoma and Bile Duct Carcinoma Treated With a Combination of Sunitinib and Gemcitabine

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Axitinib Plus Pembrolizumab Is Effective in Renal Cell Carcinoma

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy